PALISADE CAPITAL MANAGEMENT, LP - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 41 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$2,123,000
-1.3%
2,126,000
-0.7%
0.05%
-6.1%
Q2 2021$2,150,000
-70.5%
2,141,000
-70.2%
0.05%
-71.3%
Q1 2021$7,281,000
-3.0%
7,187,000
+4.4%
0.17%
-10.9%
Q4 2020$7,507,000
+9.5%
6,887,000
+4.0%
0.19%
-5.4%
Q3 2020$6,855,000
+15.9%
6,624,000
+23.3%
0.20%
+8.0%
Q2 2020$5,916,000
+19.4%
5,371,000
+10.3%
0.19%
+7.4%
Q1 2020$4,956,000
-11.2%
4,871,0000.0%0.18%
+10.8%
Q4 2019$5,580,000
+26.4%
4,871,000
+25.8%
0.16%
+17.0%
Q3 2019$4,413,000
-3.9%
3,871,0000.0%0.14%
-4.9%
Q2 2019$4,593,000
-12.2%
3,871,0000.0%0.14%
-15.5%
Q1 2019$5,231,000
-17.2%
3,871,000
-34.1%
0.17%
-27.6%
Q4 2018$6,319,000
-15.5%
5,871,000
-17.2%
0.23%
+12.1%
Q3 2018$7,474,000
+0.4%
7,093,000
-6.6%
0.21%
-3.7%
Q2 2018$7,442,000
+9.7%
7,593,000
+11.0%
0.22%
-6.5%
Q1 2018$6,785,000
-6.1%
6,843,0000.0%0.23%
-6.1%
Q4 2017$7,224,000
-0.3%
6,843,0000.0%0.24%
-5.0%
Q3 2017$7,246,000
-0.2%
6,843,0000.0%0.26%
-5.1%
Q2 2017$7,260,000
+10.2%
6,843,0000.0%0.27%
+7.9%
Q1 2017$6,591,000
+10.7%
6,843,000
+17.1%
0.25%
+12.5%
Q4 2016$5,956,000
+9.2%
5,843,000
-0.1%
0.22%
+15.5%
Q3 2016$5,453,000
+28.3%
5,849,000
-2.1%
0.19%
+26.0%
Q2 2016$4,251,000
-22.0%
5,977,0000.0%0.15%
-13.5%
Q1 2016$5,450,000
-9.5%
5,977,000
+11.7%
0.18%
-9.2%
Q4 2015$6,024,0005,350,0000.20%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC DEL in Q4 2020.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders